These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 26914709)

  • 1. Club Cell-16 and RelB as Novel Determinants of Arterial Stiffness in Exacerbating COPD Patients.
    Labonté LE; Bourbeau J; Daskalopoulou SS; Zhang M; Coulombe P; Garland K; Baglole CJ
    PLoS One; 2016; 11(2):e0149974. PubMed ID: 26914709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in the expression of the NF-κB family member RelB as a novel marker of cardiovascular outcomes during acute exacerbations of chronic obstructive pulmonary disease.
    Labonté L; Coulombe P; Zago M; Bourbeau J; Baglole CJ
    PLoS One; 2014; 9(11):e112965. PubMed ID: 25409035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Spirometrically Confirmed Chronic Obstructive Pulmonary Disease on Arterial Stiffness and Surfactant Protein D After Percutaneous Coronary Intervention. The CATEPOC Study.
    Malik K; Diaz-Coto S; de la Asunción Villaverde M; Martinez-Camblor P; Navarro-Rolon A; Pujalte F; De la Sierra A; Almagro P
    Int J Chron Obstruct Pulmon Dis; 2022; 17():2577-2587. PubMed ID: 36267326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease.
    Thomsen M; Ingebrigtsen TS; Marott JL; Dahl M; Lange P; Vestbo J; Nordestgaard BG
    JAMA; 2013 Jun; 309(22):2353-61. PubMed ID: 23757083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating surfactant protein D as a potential lung-specific biomarker of health outcomes in COPD: a pilot study.
    Sin DD; Leung R; Gan WQ; Man SP
    BMC Pulm Med; 2007 Oct; 7():13. PubMed ID: 17922919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arterial stiffness measured via carotid femoral pulse wave velocity is associated with disease severity in COPD.
    Cinarka H; Kayhan S; Gumus A; Durakoglugil ME; Erdogan T; Ezberci I; Yavuz A; Ozkaya S; Sahin U
    Respir Care; 2014 Feb; 59(2):274-80. PubMed ID: 23821765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic Utility of Biomarkers in COPD.
    Ambade VN; Sontakke AN; Barthwal MS; Tyagi R; Basannar DR
    Respir Care; 2015 Dec; 60(12):1729-42. PubMed ID: 26106205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The carotid chemoreceptor contributes to the elevated arterial stiffness and vasoconstrictor outflow in chronic obstructive pulmonary disease.
    Phillips DB; Steinback CD; Collins SÉ; Fuhr DP; Bryan TL; Wong EYL; Tedjasaputra V; Bhutani M; Stickland MK
    J Physiol; 2018 Aug; 596(15):3233-3244. PubMed ID: 29528117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular risk, myocardial injury, and exacerbations of chronic obstructive pulmonary disease.
    Patel AR; Kowlessar BS; Donaldson GC; Mackay AJ; Singh R; George SN; Garcha DS; Wedzicha JA; Hurst JR
    Am J Respir Crit Care Med; 2013 Nov; 188(9):1091-9. PubMed ID: 24033321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reproducibility of arterial stiffness and wave reflections in chronic obstructive pulmonary disease: the contribution of lung hyperinflation and a comparison of techniques.
    Stone IS; John L; Petersen SE; Barnes NC
    Respir Med; 2013 Nov; 107(11):1700-8. PubMed ID: 23920329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between serum levels of surfactant protein D in COPD exacerbation severity and mortality.
    Günaydın FE; Günlüoğlu G; Kalkan N; Aktepe EN; Demirkol B; Altın S
    Turk J Med Sci; 2019 Jun; 49(3):888-893. PubMed ID: 31083857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum surfactant protein D during acute exacerbations of chronic obstructive pulmonary disease.
    Shakoori TA; Sin DD; Ghafoor F; Bashir S; Bokhari SN
    Dis Markers; 2009; 27(6):287-94. PubMed ID: 20075511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aortic Pulse Wave Velocity as a Measure of Cardiovascular Risk in Chronic Obstructive Pulmonary Disease: Two-Year Follow-Up Data from the ARCADE Study.
    Gale NS; Albarrati AM; Munnery MM; Mcdonnell BJ; Benson VS; Singer RMT; Cockcroft JR; Shale DJ
    Medicina (Kaunas); 2019 Apr; 55(4):. PubMed ID: 30987061
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum Surfactant Protein Levels in Patients Admitted to the Hospital with Acute COPD Exacerbation.
    Papaioannou AI; Konstantelou E; Papaporfyriou A; Bartziokas K; Spathis A; Bakakos P; Loukides S; Koulouris N; Papiris S; Kostikas K
    Lung; 2018 Apr; 196(2):201-205. PubMed ID: 29445934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Club cell protein 16 and disease progression in chronic obstructive pulmonary disease.
    Park HY; Churg A; Wright JL; Li Y; Tam S; Man SF; Tashkin D; Wise RA; Connett JE; Sin DD
    Am J Respir Crit Care Med; 2013 Dec; 188(12):1413-9. PubMed ID: 24245748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exacerbations of chronic obstructive pulmonary disease.
    Wedzicha JA; Donaldson GC
    Respir Care; 2003 Dec; 48(12):1204-13; discussion 1213-5. PubMed ID: 14651761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic inflammatory biomarkers and co-morbidities of chronic obstructive pulmonary disease.
    MacNee W
    Ann Med; 2013 May; 45(3):291-300. PubMed ID: 23110517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemosensitivity, Cardiovascular Risk, and the Ventilatory Response to Exercise in COPD.
    Stickland MK; Fuhr DP; Edgell H; Byers BW; Bhutani M; Wong EY; Steinback CD
    PLoS One; 2016; 11(6):e0158341. PubMed ID: 27355356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Etiology and biomarkers of systemic inflammation in mild to moderate COPD exacerbations].
    Saldías PF; Díaz PO; Dreyse DJ; Gaggero BA; Sandoval AC; Lisboa BC
    Rev Med Chil; 2012 Jan; 140(1):10-8. PubMed ID: 22552550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased expression of the NF-κB family member RelB in lung fibroblasts from Smokers with and without COPD potentiates cigarette smoke-induced COX-2 expression.
    Sheridan JA; Zago M; Nair P; Li PZ; Bourbeau J; Tan WC; Hamid Q; Eidelman DH; Benedetti AL; Baglole CJ
    Respir Res; 2015 May; 16(1):54. PubMed ID: 25943190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.